Tag: genomics
-
A.I. Drug Discovery Company Gains $32M in Early Funds
A company using genomic databases and artificial intelligence to discover new therapies for neurodegenerative diseases is raising $32 million in its first venture funding round.
-
Exosome Technology Acquired for TBI, Stroke Therapies
A company developing therapies for brain injuries and neurodegenerative disorders is acquiring the rights to a process that treats these conditions with pieces of RNA transferred in tiny containers call exosomes.
-
FDA Issues Draft Gene Therapy Regulatory Guidance
FDA issued a series of draft documents spelling out its processes for reviewing gene therapies for three types of diseases, as well as producing and testing these treatments.
-
Big Data, A.I. Applied to Precision Medicine for Lung Disease
A medical analytics company and two academic scientists are applying artificial intelligence technologies to discover precise therapies for people with idiopathic pulmonary fibrosis, a chronic lung disease.
-
Gene Therapy Shown to Reduce Extreme High Cholesterol
A gene therapy technique that stops production of a targeted protein is shown in tests with monkeys to reduce levels of harmful cholesterol, but also expose potential risks associated with the technique.
-
Crispr Deployed to Boost Plant Disease Resistance
A plant science lab in Dallas is designing a new use of the emerging genome editing technique known as Crispr to add more resistance to plant diseases in two staple food crops.
-
Gates Backs Engineered Mosquitoes to Stop Malaria
A company that applies genetic engineering to limit the spread of disease-carrying pests is partnering with the Bill and Melinda Gates Foundation to develop mosquitoes that stop the spread of malaria.
-
UC-Berkeley Gains U.S. Crispr-Cas9 Patent
University of California received a patent for its genome editing technology known as Crispr, with the most widely used editing enzyme called Cas9.
-
Soil Microbes Yield Rich Antibiotic Sources
A group of geo- and bioscience researchers analyzed microbes residing in soil under northern California and discovered many new potential sources of antibiotics, well beyond current sources.
-
$850M Deal Kicks Off RNA Vaccine Research
Drug maker Sanofi is partnering with biotechnology company Translate Bio to develop vaccines against infectious diseases from messenger RNA, material transcribed from genetic codes in DNA.